[
    [
        {
            "time": "2020-01-01",
            "original_text": "公司主打产品甘精胰岛素注射液，在2020年先后中标白俄罗斯市场、顺利出口至土耳其、黎巴嫩、尼日尔等新兴国家，并获准在哈萨克斯坦上市销售",
            "features": {
                "keywords": [
                    "甘精胰岛素",
                    "出口",
                    "新兴国家",
                    "中标",
                    "哈萨克斯坦"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公司主打产品甘精胰岛素注射液，在2020年先后中标白俄罗斯市场、顺利出口至土耳其、黎巴嫩、尼日尔等新兴国家，并获准在哈萨克斯坦上市销售",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-06-01",
            "original_text": "甘李药业的精蛋白人胰岛素混合注射液（30R）在2021年年中取得注册批件，尚未形成大规模销售",
            "features": {
                "keywords": [
                    "精蛋白人胰岛素",
                    "注册批件",
                    "大规模销售"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业的精蛋白人胰岛素混合注射液（30R）在2021年年中取得注册批件，尚未形成大规模销售",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-01-01",
            "original_text": "甘精胰岛素（GL-GLA）已成功完成两项海外随机、多中心、III期研究",
            "features": {
                "keywords": [
                    "甘精胰岛素",
                    "海外研究",
                    "III期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘精胰岛素（GL-GLA）已成功完成两项海外随机、多中心、III期研究",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "甘李药业副总经理、美国子公司CEO Lawrence Hill的辞职不会对公司日常的生产经营带来实质性影响",
            "features": {
                "keywords": [
                    "辞职",
                    "美国子公司",
                    "生产经营"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "甘李药业副总经理、美国子公司CEO Lawrence Hill的辞职不会对公司日常的生产经营带来实质性影响",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "公司所有组别均有品种中选 A 类，在获得基础量之外还可获得 C 类调出的分配量，有利于市场份额进一步提升",
            "features": {
                "keywords": [
                    "市场份额",
                    "A类",
                    "C类",
                    "分配量"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公司所有组别均有品种中选 A 类，在获得基础量之外还可获得 C 类调出的分配量，有利于市场份额进一步提升",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "山东临沂新建厂项目的建设按照计划顺利进行中",
            "features": {
                "keywords": [
                    "新建厂",
                    "临沂",
                    "计划"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "山东临沂新建厂项目的建设按照计划顺利进行中",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-01",
            "original_text": "公司生产经营稳定向好，不存在资金打压公司股价的情况",
            "features": {
                "keywords": [
                    "生产经营",
                    "稳定向好",
                    "资金打压"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公司生产经营稳定向好，不存在资金打压公司股价的情况",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "甘李药业一糖尿病在研药物获FDA临床试验批准",
            "features": {
                "keywords": [
                    "糖尿病",
                    "FDA",
                    "临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘李药业一糖尿病在研药物获FDA临床试验批准",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-15",
            "original_text": "关于公司2021年股票期权激励计划 股票期权首次授予登记完成的公告",
            "features": {
                "keywords": [
                    "股票期权",
                    "激励计划",
                    "首次授予"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "关于公司2021年股票期权激励计划 股票期权首次授予登记完成的公告",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]